Bausch Health Companies Inc. (BVF.F)

Compare

4.7445

-0.6095

(-11.38%)

At close: April 4 at 5:12:14 PM GMT+2

Bausch + Lomb's Q1 Earnings Expected in Line With Forecasts, RBC says

Bausch + Lomb (BLCO) is set to report its Q1 results on April 30, with revenue and earnings before i

PREMIUM
MT Newswires yesterday

BHC
Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month

Bausch Health's gastroenterology business, Salix Pharmaceuticals, recognizes the complexities of irritable bowel syndrome (IBS) and seeks to make a difference in how the condition is perceived, diagnosed and treated. LAVAL, QC / ACCESS Newswire ...

ACCESS Newswire 4 days ago

BHC
Bausch + Lomb recalls Envista intraocular lenses over safety risks

J.P. Morgan analysts said it was too early to discuss the financial impact of the recall, but estimated that $70 million to $90 million of revenue could be at risk this year.

MedTech Dive 6 days ago

BHC

NVST
Bausch + Lomb Stock Sinks on 'Voluntary Recall' of Some Implantable Eye Lenses

Bausch + Lomb shares tumbled in intraday trading Friday, a day after the eye-care company announced a "voluntary recall" of some of its intraocular lenses due to safety concerns.

Investopedia 8 days ago

BHC
Why Bausch + Lomb (BLCO) Shares Are Plunging Today

Shares of eyecare company Bausch + Lomb (NYSE:BLCO) fell 6.7% in the morning session after Wells Fargo downgraded the stock's rating from Buy to Hold. The firm cited concerns related to the "voluntary recall" of certain implantable eye lenses reported the previous day.

StockStory 8 days ago

BHC

BLCO
WF downgrades Bausch + Lomb on enVista recall giving a near-term uncertainty

Investing.com -- Wells Fargo downgraded Bausch + Lomb Corp to Equal Weight from Overweight on uncertainty from the voluntary recall of its enVista intraocular lenses (IOLs), which is expected to weigh on sales growth, earnings, and investor sentiment. Brokerage cut its price target to $15 from $24, based on 9.5x its 2026 EBITDA estimate of $1.0 billion.

Investing.com 8 days ago

BHC
Why Bausch + Lomb (BLCO) Stock Is Nosediving

Shares of eyecare company Bausch + Lomb (NYSE:BLCO) fell 10.6% in the afternoon session after the company announced the voluntary recall of intraocular lenses on its enVista platform. The recall was due to the reports of toxic anterior segment syndrome (TASS, a potential complication in any cataract surgery). The recall may raise short-term concerns regarding product safety and regulatory scrutiny. Though the company emphasized that the reported cases of TASS involved only an extremely small fra

StockStory 9 days ago

BHC

BLCO
Bausch + Lomb announces intraocular lens recall

TASS is an inflammatory reaction within the eye that can arise from several causes.

Medical Device Network 9 days ago

BHC
Bausch Health to Announce First Quarter Results on April 30

LAVAL, QC / ACCESS Newswire / March 27, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release first quarter financial results after market close on Wednesday, April 30, 2025. Bausch Health will host a conference call and live webcast ...

ACCESS Newswire 10 days ago

BHC
Bausch Health Prices Upsized Private Offering of Senior Secured Notes

Bausch Health Companies (BHC.TO, BHC) on Tuesday priced its previously announced offering of US$4.4

PREMIUM
MT Newswires 11 days ago

BHC
Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes

LAVAL, QC / ACCESS Newswire / March 25, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") today announced that it has priced its previously announced offering (the "Offering") of $4.4 billion aggregate principal ...

ACCESS Newswire 11 days ago

BHC
Discover 3 Top Growth Companies With Significant Insider Ownership

As the United States market experiences a rally with major indices like the S&P 500 and Nasdaq posting gains, investor sentiment is buoyed by reports of potential tariff reductions. In this environment, growth companies with significant insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the company's operations and prospects.

Simply Wall St. 12 days ago

BHC

LQDA

ALTI
Shareholders in Bausch Health Companies (NYSE:BHC) are in the red if they invested three years ago

Investing in stocks inevitably means buying into some companies that perform poorly. But long term Bausch Health...

Simply Wall St. 15 days ago

BHC
Bausch Health Announces Conditional Redemption of Senior Notes

LAVAL, QC / ACCESS Newswire / March 21, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") today announced that (i) it has delivered conditional notices of redemption for all of its outstanding 5.500% Senior ...

ACCESS Newswire 15 days ago

BHC
Bausch (BHC) Down 0.7% Since Last Earnings Report: Can It Rebound?

Bausch (BHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks 15 days ago

BHC
Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities

Transaction is part of a broader refinancing initiative aimed at opportunistically accessing capital markets to address near- and mid-term maturities LAVAL, QC / ACCESS Newswire / March 19, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the ...

ACCESS Newswire 17 days ago

BHC
Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes

LAVAL, QC / ACCESS Newswire / March 19, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") today announced that it has launched an offering (the "Offering") of $4.0 billion aggregate principal amount of new ...

ACCESS Newswire 17 days ago

BHC
Bausch + Lomb Launches Lens System in U.S.

Bausch + Lomb (BLCO.TO) on Monday announced the U.S. launch of Arise, a lens fitting system that str

PREMIUM
MT Newswires 20 days ago

BHC
Bausch Health announces next steps in financining initiative

Bausch Health (BHC) Companies provided an update on its financing plans. The Company announced that it has engaged J.P. Morgan in connection with the Company’s previously announced financing objectives. Any transactions would be subject to market and other conditions and there can be no assurance that the Company will be able to successfully complete any transaction on acceptable terms or at all. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news

TipRanks 22 days ago

BHC
Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan

LAVAL, QC / ACCESS Newswire / March 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company enriching lives through a relentless drive to deliver better health outcomes, today provided an update on ...

ACCESS Newswire 23 days ago

BHC

Performance Overview

Return	BVF.F	S&P/TSX Composite index (^GSPTSE)
YTD	-34.52%	-5.80%
1-Year	-49.66%	+5.18%
3-Year	-77.08%	+5.02%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Bausch Health Companies Inc. (BVF.F)

Bausch + Lomb's Q1 Earnings Expected in Line With Forecasts, RBC says

Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month

Bausch + Lomb recalls Envista intraocular lenses over safety risks

Bausch + Lomb Stock Sinks on 'Voluntary Recall' of Some Implantable Eye Lenses

Why Bausch + Lomb (BLCO) Shares Are Plunging Today

WF downgrades Bausch + Lomb on enVista recall giving a near-term uncertainty

Why Bausch + Lomb (BLCO) Stock Is Nosediving

Bausch + Lomb announces intraocular lens recall

Bausch Health to Announce First Quarter Results on April 30

Bausch Health Prices Upsized Private Offering of Senior Secured Notes

Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes

Discover 3 Top Growth Companies With Significant Insider Ownership

Shareholders in Bausch Health Companies (NYSE:BHC) are in the red if they invested three years ago

Bausch Health Announces Conditional Redemption of Senior Notes

Bausch (BHC) Down 0.7% Since Last Earnings Report: Can It Rebound?

Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities

Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes

Bausch + Lomb Launches Lens System in U.S.

Bausch Health announces next steps in financining initiative

Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan

Performance Overview